A physiology-based, integrative eye-care program that aims to support the eye's natural resilience, alongside the care your ophthalmologist provides.
Request a Consultation
Netra Restoration Therapy (NRT) is a physiology-based, integrative eye-care program that aims to support the eye's natural resilience mechanisms. It combines modern biological understanding of retinal and optic nerve function with treatment principles rooted in Traditional Chinese Medicine and Ayurveda. NRT is adjunctive care: it is used alongside the diagnosis, monitoring and treatment your ophthalmologist provides, never instead of them.
At its core, NRT focuses on ocular blood flow regulation, neurotrophic support for retinal and optic nerve cells, and damaging processes such as ferroptosis, oxidative stress and chronic ocular inflammation.
Better regulation. Stronger protection. More resilient vision.
Many progressive eye conditions develop even when standard clinical markers appear "acceptable." This happens because vision depends on more than structure alone - it depends on how well the eye adapts to stress.
Netra Restoration Therapy focuses on:
By supporting these core processes, this Eye Care Therapy (NRT) aims to improve the eye's ability to tolerate daily physiological challenges and aging-related stressors.

Healthy vision requires stable, well-regulated blood flow to the retina and optic nerve. Even brief fluctuations in perfusion can disrupt oxygen delivery and waste removal, accelerating tissue stress.
Netra Restoration Therapy emphasizes:
The aim is a more consistent supply of oxygen and nutrients, which matters especially for the highly energy-dependent retinal ganglion cells and photoreceptors.
The retina and optic nerve are extensions of the central nervous system. Their survival depends on continuous neurotrophic signaling - chemical support messages that promote cell survival, repair, and synaptic function.
NRT is designed to:
This neuroprotective focus is especially important in conditions where nerve damage progresses silently over time.
Ferroptosis is a form of programmed cell death driven by iron accumulation and lipid peroxidation. The retina is particularly vulnerable due to its high metabolic rate and rich lipid content.
Netra Restoration Therapy targets this pathway by:
Lab studies suggest ferroptosis contributes to retinal cell loss, which is why it is one of the pathways NRT targets.
Low-grade inflammation and oxidative stress often persist beneath the surface long before structural damage becomes visible on imaging.
NRT aims to:
This approach recognizes that inflammation is not merely a reaction - but often a driver of disease progression.
Some individuals tolerate pressure changes, vascular fluctuations, or metabolic stress without developing vision loss - while others do not. The difference lies in ocular resilience.
Netra Restoration Therapy aims to support that resilience by:
This Eye Care Therapy (NRT) looks at these factors alongside the treatment targets your ophthalmologist sets, such as eye pressure in glaucoma.

Netra Restoration Therapy looks at vascular, neurological and inflammatory pathways together, as support for long-term eye health alongside standard eye care.
Vision isn't just about seeing clearly today - it's about protecting the systems that allow you to see tomorrow.
What is possible for any individual depends on the condition, the extent of existing damage and the stage at which care begins. NRT is adjunctive care offered alongside ophthalmologist-directed treatment; it is not a cure and results are not guaranteed. The areas below are what the program targets and what is documented at each visit so that change over time can be assessed.
NRT targets contributing factors beyond intraocular pressure, including ocular blood-flow regulation, inflammation, oxidative stress and neurotrophic support. It is not a pressure-lowering treatment and does not replace drops, laser or surgery. In glaucoma, lowering eye pressure is the only treatment proven to slow vision loss, and no current treatment, including NRT, can restore vision already lost to the disease. NRT is used alongside pressure-lowering treatment, never instead of it. Progression of the underlying condition is tracked by your ophthalmologist through visual-field testing, OCT and pressure monitoring; NRT does not replace that monitoring.
Where a visual-field baseline is available, changes during care are compared against it. Results vary between patients and no specific change is guaranteed. In glaucoma, NRT does not restore visual field that has already been lost.
Distance and near acuity are recorded at intake and at follow-up visits so that any change during care is documented. Acuity is one measure among several rather than the main endpoint.
Contrast sensitivity, the ability to distinguish shapes, edges and detail against similar backgrounds, is assessed as part of the functional-vision review.
Patients are asked about brightness perception, color, and low-light or night-time function, because these affect mobility and daily activities and are not captured by an acuity chart alone.
Glare, light sensitivity and comfort in bright environments such as sunlight, headlights and digital screens are recorded at each visit as part of the functional-vision review.
Eye strain and ocular discomfort are documented at each visit as reported by the patient, alongside the objective measures above.
"I recently completed my three weeks of Netra Restoration Therapy and I am already seeing major improvements with the reduction in my eye prescription correction numbers. Netra Eye Institute is not just a well equipped clinic with modern ophthalmic instruments but is also backed up by professional and patient-caring staff. Thank you Dr. Gandapodi for your services and care."
- Sarang, Grateful Netra Patient
NRT's approach draws on research suggesting that reduced ocular blood flow, ongoing nerve-cell loss and cellular stress contribute to many eye diseases. The studies listed below tested single herbal compounds or extracts against oxidative stress, inflammation, ferroptosis and other kinds of cell damage in the eye. They were done in lab-grown cells or animals, not in people, and none tested NRT, so they explain the reasoning behind the program rather than show that it works.
Evidence scope: These sources support the biological mechanisms or individual treatment components discussed on this page. None directly evaluates the complete proprietary Netra Restoration Therapy protocol, and they should not be interpreted as proof that NRT treats, cures, or prevents an eye disease.